Genetic diversity of CYP3A5 and ABCB1 variants in East-Central and South European populations

References

• Adler G, Garstka A, Valjevac A, Czerska E, Kiseljakovic E, Salkic NN. 2015. Prevalence of genetic prothrombotic risk factors: 1691G > A FV, 20210G > A PT and 677C > T MTHFR mutations in the Bosnian population. Ann Hum Biol. 42(6):576–580.
   PubMed Web of Science ®Google Scholar
• Al-Eitan LN. 2020. Pharmacogenomic landscape of VIP genetic variants in Jordanian Arabs and comparison with worldwide populations. Gene. 737:144408.
   PubMed Web of Science ®Google Scholar
• Arnold FL, Fukunaga S, Kusama M, Matsuki N, Ono S. 2014. Assessment of factors associated with dose differences between Japan and the United States. Clin Pharmacol Ther. 95(5):542–549.
   PubMed Web of Science ®Google Scholar
• Arvanitidis K, Ragia G, Iordanidou M, Kyriaki S, Xanthi A, Tavridou A, Manolopoulos VG. 2007. Genetic polymorphisms of drug-metabolizing enzymes CYP2D6, CYP2C9, CYP2C19 and CYP3A5 in the Greek population. Fundam Clin Pharmacol. 21(4):419–426.
   PubMed Web of Science ®Google Scholar
• Atanasova SY, von Ahsen N, Toncheva DI, Dimitrov TG, Oellerich M, Armstrong VW. 2005. Genetic polymorphisms of cytochrome P450 among patients with Balkan endemic nephropathy (BEN). Clin Biochem. 38(3):223–228.
   PubMed Web of Science ®Google Scholar
• Benavides R, Vsevolozhskaya O, Cattaneo S, Zaykin D, Brenton A, Parisien M, Verma V, et al. 2020. A functional polymorphism in the ATP-Binding Cassette B1 transporter predicts pharmacologic response to combination of nortriptyline and morphine in neuropathic pain patients. Pain. 161(3):619–629.
   PubMed Web of Science ®Google Scholar
• R Core Team 2021. Bird Hippie (Copyright (C) 2021. The R Foundation for Statistical Computing, Platform: x86_64-w64-mingw32/x64 (64-bit). R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing.
   Google Scholar
• Brinar M, Cukovic-Cavka S, Bozina N, Grubelic Ravic K, Markos P, Ladic A, Cota M, et al. 2013. MDR1 polymorphisms are associated with inflammatory bowel disease in a cohort of Croatian IBD patients. BMC Gastroenterol. 13:57.
   PubMed Web of Science ®Google Scholar
• Cacabelos R. 2020. Pharmacogenomics of cognitive dysfunction and neuropsychiatric disorders in dementia. IJMS. 2621(9):3059.
   Google Scholar
• Campa D, Sainz J, Pardini B, Vodickova L, Naccarati A, Rudolph A, Novotny J, et al. 2012. A comprehensive investigation on common polymorphisms in the MDR1/ABCB1 transporter gene and susceptibility to colorectal cancer. PLOS One. 7(3):e32784.
   PubMed Web of Science ®Google Scholar
• Chen L, Prasad GVR. 2018. CYP3A5 polymorphisms in renal transplant recipients: influence on tacrolimus treatment. Pharmgenomics Pers Med. 711:23–33.
   Google Scholar
• Cizmarikova M, Podracka L, Klimcakova L, Habalova V, Boor A, Mojzis J, Mirossay L. 2015. MDR1 polymorphisms and idiopathic nephrotic syndrome in Slovak children: preliminary results. Med Sci Monit. 21:59–68.
   PubMed Web of Science ®Google Scholar
• Daly AK. 2006. Significance of the minor cytochrome P450 3A isoforms. Clin Pharmacokinet. 45(1):13–31.
   PubMed Web of Science ®Google Scholar
• Dong Q, Xu B, Tan Y, Liu Z, Tian L, Zhang B, Lin CK, et al. 2009. The genetic variability of MDR1 C3435T polymorphisms in four Southern Chinese populations. Biomed Pharmacother. 63(9):658–662.
   PubMed Web of Science ®Google Scholar
• Ehmann F, Caneva L, Prasad K, Paulmichl M, Maliepaard M, Llerena A, Ingelman-Sundberg M, Papaluca-Amati M. 2015. Pharmacogenomic information in drug labels: European Medicines Agency perspective. Pharmacogenomics J. 15(3):201–210.
   PubMed Web of Science ®Google Scholar
• Engen RM, Marsh S, Van Booven DJ, McLeod HL. 2006. Ethnic differences in pharmacogenetically relevant genes. Curr Drug Targets. 7(12):1641–1648.
   PubMed Web of Science ®Google Scholar
• Fortinguerra S, Sorrenti V, Giusti P, Zusso M, Buriani A. 2019. Pharmacogenomic characterization in bipolar spectrum disorders. Pharmaceutics. 12(1):13.
   Web of Science ®Google Scholar
• Gaikovitch EA, Cascorbi I, Mrozikiewicz PM, Brockmöller J, Frötschl R, Köpke K, Gerloff T, et al. 2003. Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population. Eur J Clin Pharmacol. 59(4):303–312.
   PubMed Web of Science ®Google Scholar
• Gall VLL, Klafke GM, Torres TT. 2018. Detoxification mechanisms involved in ivermectin resistance in the cattle tick, Rhipicephalus (Boophilus) microplus. Sci Rep. 8(1):12401.
   PubMedGoogle Scholar
• Ganoci L, Bozina T, Mirosevic Skvrce N, Lovric M, Mas P, Bozina N. 2017. Genetic polymorphisms of cytochrome P450 enzymes: CYP2C9, CYP2C19, CYP2D6, CYP3A4, and CYP3A5 in the Croatian population. Drug Metab Pers Ther. 32(1):11–21.
   PubMedGoogle Scholar
• Gazouli M, Zacharatos P, Gorgoulis V, Mantzaris G, Papalambros E, Ikonomopoulos J. 2004. The C3435T MDR1 gene polymorphism is not associated with susceptibility for ulcerative colitis in Greek population. Gastroenterology. 126(1):367–369.
   PubMed Web of Science ®Google Scholar
• Gellner K, Eiselt R, Hustert E, Arnold H, Koch I, Haberl M, Deglmann CJ, et al. 2001. Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene. Pharmacogenetics. 11(2):111–121.
   PubMedGoogle Scholar
• Gervasini G, Vizcaino S, Gasiba C, Carrillo JA, Benitez J. 2005. Differences in CYP3A5*3 genotype distribution and combinations with other polymorphisms between Spaniards and Other Caucasian populations. Ther Drug Monit. 27(6):819–821.
   PubMed Web of Science ®Google Scholar
• Gibson GG, Plant NJ, Swales KE, Ayrton A, El-Sankary W. 2002. Receptor-dependent transcriptional activation of cytochrome P450 3A genes: induction mechanisms, species differences and interindividual variation in man. Xenobiotica. 32(3):165–206.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Galarza FF, McCabe A, Santos EJ, Jones J, Takeshita LY, Ortega-Rivera ND, Ghattaoraya G, et al. 2020. Allele frequency net database (AFND) 2020 update: gold-standard data classification, open access genotype data and new query tools. Nucleic Acids Res. 48(D1):D783–788.
   PubMed Web of Science ®Google Scholar
• He Y, Yang H, Geng T, Feng T, Yuan D, Kang L, Luo M, Jin T. 2015. Genetic polymorphisms of pharmacogenomics VIP variants in the Ihoba population of Southwest China. Int J Clin Exp Pathol. 8(10):13293–13303.
   PubMed Web of Science ®Google Scholar
• Hodges LM, Markova SM, Chinn LW, Gow JM, Kroetz DL, Klein TE, Altman RB. 2011. Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein). Pharmacogenet Genomics. 21(3):152–161.
   PubMed Web of Science ®Google Scholar
• Hoggart CJ, O'Reilly PF, Kaakinen M, Zhang W, Chambers JC, Kooner JS, Coin LJM, Jarvelin M-R. 2012. Fine-scale estimation of location of birth from genome-wide single-nucleotide polymorphism data. Genetics. 190(2):669–677.
   PubMed Web of Science ®Google Scholar
• Kamvar ZN, Brooks JC, Grunwald NJ. 2015. Novel R tools for analysis of genome-wide population genetic data with emphasis on clonality. Front Genet. 6:208.
   PubMed Web of Science ®Google Scholar
• Kamvar ZN, Tabima JF, Grunwald NJ. 2014. Poppr: an R package for genetic analysis of populations with clonal, partially clonal, and/or sexual reproduction. Peer J. 2:e281.
   PubMed Web of Science ®Google Scholar
• Kapedanovska Nestorovska A, Jakovski K, Naumovska Z, Hiljadnikova Bajro M, Sterjev Z, Eftimov A, Matevska Geskovska N, et al. 2014. Distribution of the most common genetic variants associated with a variable drug response in the population of the Republic of Macedonia. Balkan J Med Genet. 17(2):5–14.
   PubMed Web of Science ®Google Scholar
• Kolovou G, Kolovou V, Ragia G, Mihas C, Diakoumakou O, Vasiliadis I, Mavrogeni S, et al. 2015. CYP3A5 genotyping for assessing the efficacy of treatment with simvastatin and atorvastatin. Genet Mol Biol. 38(2):129–137.
   PubMed Web of Science ®Google Scholar
• Krasniqi V, Dimovski A, Bytyqi HQ, Eftimov A, Simicevic L, Bozina N. 2017. Genetic polymorphisms of CYP2C9, CYP2C19, and CYP3A5 in Kosovar population. Arh Hig Rada Toksikol. 68(3):180–184.
   PubMed Web of Science ®Google Scholar
• Kristiansen W, Haugen TB, Witczak O, Andersen JM, Fossa SD, Aschim EL. 2011. CYP1A1, CYP3A5 and CYP3A7 polymorphisms and testicular cancer susceptibility. Int J Androl. 34(1):77–83.
   PubMedGoogle Scholar
• Lao O, Lu TT, Nothnagel M, Junge O, Freitag-Wolf S, Caliebe A, Balascakova M, et al. 2008. Correlation between genetic and geographic structure in Europe. Curr Biol. 18(16):1241–1248.
   PubMed Web of Science ®Google Scholar
• Mijac D, Vukovic-Petrovic I, Mijac V, Perovic V, Milic N, Djuranovic S, Bojic D, et al. 2018. MDR1 gene polymorphisms are associated with ulcerative colitis in a cohort of Serbian patients with inflammatory bowel disease. PLOS One. 13(3):e0194536.
   PubMed Web of Science ®Google Scholar
• Mustafina OE, Tuktarova IA, Karimov DD, Somova R, Nasibullin TR. 2015. CYP2D6, CYP3A5, and CYP3A4 gene polymorphism in Russian, Tatar, and Bashkir populations. [Article in Russian]. Genetika. 51(1):109–119.
   Web of Science ®Google Scholar
• Naumovska Z, Nestorovska AK, Sterjev Z, Filipce A, Dimovski A, Suturkova L. 2014. Genotype variability and haplotype profile of ABCB1 (MDR1) gene polymorphisms in Macedonian population. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 35(3):121–133.
   PubMedGoogle Scholar
• Novembre J, Johnson T, Bryc K, Kutalik Z, Boyko AR, Auton A, Indap A, et al. 2008. Genes mirror geography within Europe. Nature. 456(7218):98–101.
   PubMed Web of Science ®Google Scholar
• Potocnik U, Glavac D, Dean M. 2008. Common germline MDR1/ABCB1 functional polymorphisms and haplotypes modify susceptibility to colorectal cancers with high microsatellite instability. Cancer Genet Cytogenet. 183(1):28–34.
   PubMedGoogle Scholar
• Price AL, Helgason A, Palsson S, Stefansson H, St Clair D, Andreassen OA, Reich D, et al. 2009. The impact of divergence time on the nature of population structure: an example from Iceland. PLOS Genet. 5(6):e1000505.
   PubMed Web of Science ®Google Scholar
• Raymond J, Imbert L, Cousin T, Duflot T, Varin R, Wils J, Lamoureux F. 2021. Pharmacogenetics of direct oral anticoagulants: a systematic review. JPM. 11(1):37.
   Google Scholar
• Salmela E, Lappalainen T, Liu J, Sistonen P, Andersen PM, Schreiber S, Savontaus ML, et al. 2011. Swedish population substructure revealed by genome-wide single nucleotide polymorphism data. PLOS One. 6(2):e16747.
   PubMed Web of Science ®Google Scholar
• Schaeffeler E, Eichelbaum M, Brinkmann U, Penger A, Asante-Poku S, Zanger UM, Schwab M. 2001. Frequency of C3435T polymorphism of MDR1 gene in African people. Lancet. 358(9279):383–384.
   PubMed Web of Science ®Google Scholar
• Shao J, Wang C, Fu P, Chen F, Zhang Y, Wei J. 2020. Impact of donor and recipient CYP3A5*3 genotype on tacrolimus population pharmacokinetics in Chinese adult liver transplant recipients. Ann Pharmacother. 54(7):652–661.
   PubMed Web of Science ®Google Scholar
• Siddiqui A, Kerb R, Weale ME, Brinkmann U, Smith A, Goldstein DB, Wood NW, Sisodiya SM. 2003. Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. N Engl J Med. 348(15):1442–1448.
   PubMed Web of Science ®Google Scholar
• Sipeky C, Csongei V, Jaromi L, Safrany E, Maasz A, Takacs I, Beres J, et al. 2011. Genetic variability and haplotype profile of MDR1 (ABCB1) in Roma and Hungarian population samples with a review of the literature. Drug Metab Pharmacokinet. 26(2):206–215.
   PubMed Web of Science ®Google Scholar
• Siuda ER, Carr R, Rominger DH, Violin JD. 2017. Biased mu-opioid receptor ligands: a promising new generation of pain therapeutics. Curr Opin Pharmacol. 32:77–84.
   PubMed Web of Science ®Google Scholar
• Sychev DA, Levanov AN, Shelekhova TV, Bochkov PO, Denisenko NP, Ryzhikova KA, Mirzaev KB, et al. 2018. The impact of ABCB1 (rs1045642 and rs4148738) and CES1 (rs2244613) gene polymorphisms on dabigatran equilibrium peak concentration in patients after total knee arthroplasty. PGPM. 11:127–137.
   Google Scholar
• Todorova Petrova D, Nedeva P, Maslyankov S, Toshev S, Yaramov N, Atanasova S, Toncheva D, et al. 2008. No association between MDR1 (ABCB1) 2677G > T and 3435C > T polymorphism and sporadic colorectal cancer among Bulgarian patients. J Cancer Res Clin Oncol. 134(3):317–322.
   PubMed Web of Science ®Google Scholar
• Turolo S, Tirelli AS, Ferraresso M, Ghio L, Belingheri M, Groppali E, Torresani E, Edefonti A. 2010. Frequencies and roles of CYP3A5, CYP3A4 and ABCB1 single nucleotide polymorphisms in Italian teenagers after kidney transplantation. Pharmacol Rep. 62(6):1159–1169.
   PubMed Web of Science ®Google Scholar
• van Schaik RH, van der Heiden IP, van den Anker JN, Lindemans J. 2002. CYP3A5 variant allele frequencies in Dutch Caucasians. Clin Chem. 48(10):1668–1671.
   PubMed Web of Science ®Google Scholar
• Vijayan NN, Mathew A, Balan S, Natarajan C, Nair CM, Allencherry PM, Banerjee M. 2012. Antipsychotic drug dosage and therapeutic response in schizophrenia is influenced by ABCB1 genotypes: a study from a south Indian perspective. Pharmacogenomics. 13(10):1119–1127.
   PubMed Web of Science ®Google Scholar
• Zanger UM, Klein K, Thomas M, Rieger JK, Tremmel R, Kandel BA, Klein M, Magdy T. 2014. Genetics, epigenetics, and regulation of drug-metabolizing cytochrome p450 enzymes. Clin Pharmacol Ther. 95(3):258–261.
   PubMed Web of Science ®Google Scholar
• Zineh I, Pacanowski MA. 2011. Pharmacogenomics in the assessment of therapeutic risks versus benefits: inside the United States Food and Drug Administration. Pharmacotherapy. 31(8):729–735.
   PubMed Web of Science ®Google Scholar